Du, Y. (2024) “Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study ”, Dermatology Practical & Conceptual, 14(1), p. e2024026. doi:10.5826/dpc.1401a26.